FFCP PHASE1:Hg19::chr12:40953952..40953977,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C156 | |||
|description=CAGE_peak_at_chr12:40953952..40953977,+ | |||
|id=chr12:40953952..40953977,+ | |||
|ontology_enrichment_celltype=CL:0000945!2.89e-50!24;CL:0000826!2.89e-50!24;CL:0000946!2.16e-26!1;CL:0000786!2.16e-26!1;CL:0000980!2.16e-26!1;CL:0000838!2.46e-23!52;CL:0000542!6.72e-23!53;CL:0000051!6.72e-23!53;CL:0000785!6.43e-14!2;CL:0000955!6.43e-14!2;CL:0000818!6.43e-14!2;CL:0000954!6.43e-14!2;CL:0000816!6.43e-14!2;CL:0002087!3.83e-10!119;CL:0002031!9.78e-10!124;CL:0000817!1.01e-09!3;CL:0000738!1.27e-08!140;CL:0002032!2.62e-07!165;CL:0000837!2.62e-07!165;CL:0000037!5.24e-07!172;CL:0000566!5.24e-07!172 | |||
|ontology_enrichment_celltype_v019=CL:0000945;1.86e-42;24!CL:0000946;7.48e-30;1!CL:0000786;7.48e-30;1!CL:0000542;5.69e-09;53 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,1.86e-42,24;CL:0000826,1.86e-42,24;CL:0000946,7.48e-30,1;CL:0000786,7.48e-30,1;CL:0000980,7.48e-30,1;CL:0000838,7.83e-20,52;CL:0000542,1.82e-19,53;CL:0000051,1.82e-19,53;CL:0000785,1.15e-15,2;CL:0000955,1.15e-15,2;CL:0000818,1.15e-15,2;CL:0000954,1.15e-15,2;CL:0000816,1.15e-15,2;CL:0000817,6.73e-11,3;CL:0002087,5.00e-09,115;CL:0002031,1.16e-08,120;CL:0000738,1.15e-07,136 | |||
|ontology_enrichment_development_v019=CL:0000954;1.15e-15;2!CL:0000051;5.69e-09;53 | |||
|ontology_enrichment_disease=DOID:630!4.61e-26!1;DOID:0050177!4.61e-26!1;DOID:0050427!4.61e-26!1;DOID:2355!1.26e-25!1;DOID:74!1.55e-13!2;DOID:0060058!8.47e-11!10;DOID:1287!2.04e-07!4 | |||
|ontology_enrichment_disease_v019=DOID:630;1.54e-29;1!DOID:0050177;1.54e-29;1!DOID:0050427;1.54e-29;1 | |||
|ontology_enrichment_disease_v019_2=DOID:630,1.78e-29,1;DOID:0050177,1.78e-29,1;DOID:0050427,1.78e-29,1 | |||
|ontology_enrichment_uberon=UBERON:0002106!1.54e-09!3;UBERON:0004854!1.54e-09!3;UBERON:0009034!1.54e-09!3;UBERON:0002095!1.54e-09!3;UBERON:0004782!1.54e-09!3;UBERON:0003281!1.54e-09!3;UBERON:0009664!1.54e-09!3;UBERON:0002296!1.54e-09!3;UBERON:0005602!1.54e-09!3;UBERON:0001179!1.54e-09!3;UBERON:0006293!1.54e-09!3 | |||
|ontology_enrichment_uberon_v019=UBERON:0002106;1.09e-10;3!UBERON:0004177;6.39e-07;5!UBERON:0005057;6.39e-07;5 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002106,1.09e-10,3;UBERON:0004854,1.09e-10,3;UBERON:0009034,1.09e-10,3;UBERON:0002095,1.09e-10,3;UBERON:0004782,1.09e-10,3;UBERON:0003281,1.09e-10,3;UBERON:0009664,1.09e-10,3;UBERON:0002296,1.09e-10,3;UBERON:0005602,1.09e-10,3;UBERON:0001179,1.09e-10,3;UBERON:0006293,1.09e-10,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.3158097759734,7.47115363994506,6.37557328640802,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.6001024709939,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.169346664131569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48.7439767360946,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.69782276922237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.05250683067112 | |||
|short_description=p@chr12:40953952..40953977,+ | |||
}} |
Revision as of 12:59, 11 January 2014
Short description: | p@chr12:40953952..40953977, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr12:40953952..40953977, + |
Coexpression cluster: | C156_plasma_splenic_hereditary_B_large_xeroderma_b |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 1.86e-42 | 24 |
pro-B cell | 1.86e-42 | 24 |
antibody secreting cell | 7.48e-30 | 1 |
plasma cell | 7.48e-30 | 1 |
plasmablast | 7.48e-30 | 1 |
lymphoid lineage restricted progenitor cell | 7.83e-20 | 52 |
lymphocyte | 1.82e-19 | 53 |
common lymphoid progenitor | 1.82e-19 | 53 |
mature B cell | 1.15e-15 | 2 |
pre-B-II cell | 1.15e-15 | 2 |
transitional stage B cell | 1.15e-15 | 2 |
small pre-B-II cell | 1.15e-15 | 2 |
immature B cell | 1.15e-15 | 2 |
precursor B cell | 6.73e-11 | 3 |
nongranular leukocyte | 5.00e-09 | 115 |
hematopoietic lineage restricted progenitor cell | 1.16e-08 | 120 |
leukocyte | 1.15e-07 | 136 |
Ontology term | p-value | n |
---|---|---|
spleen | 1.09e-10 | 3 |
gastrointestinal system mesentery | 1.09e-10 | 3 |
stomach region | 1.09e-10 | 3 |
mesentery | 1.09e-10 | 3 |
gastrointestinal system serosa | 1.09e-10 | 3 |
mesentery of stomach | 1.09e-10 | 3 |
gut mesentery | 1.09e-10 | 3 |
dorsal mesentery | 1.09e-10 | 3 |
dorsal mesogastrium | 1.09e-10 | 3 |
peritoneal cavity | 1.09e-10 | 3 |
spleen primordium | 1.09e-10 | 3 |
Ontology term | p-value | n |
---|---|---|
genetic disease | 1.78e-29 | 1 |
monogenic disease | 1.78e-29 | 1 |
xeroderma pigmentosum | 1.78e-29 | 1 |